|
1
|
Tan P and Yeoh KG: Genetics and molecular
pathogenesis of gastric adenocarcinoma. Gastroenterology.
149:1153–1162.e3. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McLean MH and El-Omar EM: Genetics of
gastric cancer. Nat Rev Gastroenterol Hepatol. 11:664–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilusz JE: Long noncoding RNAs: Re-writing
dogmas of RNA processing and stability. Biochim Biophys Acta.
1859:128–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barrett SP, Wang PL and Salzman J:
Circular RNA biogenesis can proceed through an exon-containing
lariat precursor. Elife. 4:e075402015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Salzman J, Chen RE, Olsen MN, Wang PL and
Brown PO: Cell-type specific features of circular RNA expression.
PLoS Genet. 9:e10037772013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y, Li C, Tan C and Liu X: Circular
RNAs: A new frontier in the study of human diseases. J Med Genet.
53:359–365. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao ZJ and Shen J: Circular RNA
participates in the carcinogenesis and the malignant behavior of
cancer. RNA Biol. 14:514–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ghosal S, Das S, Sen R, Basak P and
Chakrabarti J: Circ2Traits: A comprehensive database for circular
RNA potentially associated with disease and traits. Front Genet.
4:2832013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li P, Chen S, Chen H, Mo X, Li T, Shao Y,
Xiao B and Guo J: Using circular RNA as a novel type of biomarker
in the screening of gastric cancer. Clin Chim Acta. 444:132–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012.PubMed/NCBI
|
|
18
|
Wang YH, Yu XH, Luo SS and Han H:
Comprehensive circular RNA profiling reveals that circular
RNA100783 is involved in chronic CD28-associated CD8(+)T cell
ageing. Immun Ageing. 12:172015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu X, Tan X and Fu SW: May Circulating
microRNAs be gastric cancer diagnostic biomarkers. J Cancer.
6:1206–1213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thomas J, Ohtsuka M, Pichler M and Ling H:
MicroRNAs: clinical relevance in colorectal cancer. Int J Mol Sci.
16:28063–28076. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Inamura K and Ishikawa Y: MicroRNA in lung
cancer: Novel biomarkers and potential tools for treatment. J Clin
Med. 5:pii: E36. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heneghan HM, Miller N and Kerin MJ: MiRNAs
as biomarkers and therapeutic targets in cancer. Curr Opin
Pharmacol. 10:543–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Song YX and Wang ZN: Non-coding
RNAs in gastric cancer. Gene. 560:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng G and Sui G: Noncoding RNA in
oncogenesis: A new era of identifying key players. Int J Mol Sci.
14:18319–18349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pak MG, Lee CH, Lee WJ, Shin DH and Roh
MS: Unique microRNAs in lung adenocarcinoma groups according to
major TKI sensitive EGFR mutation status. Diagn Pathol. 10:992015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng N, Cai W, Ren S, Li X, Wang Q, Pan
H, Zhao M, Li J, Zhang Y, Zhao C, et al: Long non-coding RNA UCA1
induces non-T790M acquired resistance to EGFR-TKIs by activating
the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer.
Oncotarget. 6:23582–23593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G
and Sun B: LINC00152 promotes proliferation in hepatocellular
carcinoma by targeting EpCAM via the mTOR signaling pathway.
Oncotarget. 6:42813–42824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rajbhandari R, McFarland BC, Patel A,
Gerigk M, Gray GK, Fehling SC, Bredel M, Berbari NF, Kim H, Marks
MP, et al: Loss of tumor suppressive microRNA-31 enhances
TRADD/NF-κB signaling in glioblastoma. Oncotarget. 6:17805–17816.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S and
Purow B: microRNA-7 inhibits the epidermal growth factor receptor
and the Akt pathway and is down-regulated in glioblastoma. Cancer
Res. 68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suto T, Yokobori T, Yajima R, Morita H,
Fujii T, Yamaguchi S, Altan B, Tsutsumi S, Asao T and Kuwano H:
MicroRNA-7 expression in colorectal cancer is associated with poor
prognosis and regulates cetuximab sensitivity via EGFR regulation.
Carcinogenesis. 36:338–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao XD, Lu YY, Guo H, Xie HH, He LJ, Shen
GF, Zhou JF, Li T, Hu SJ, Zhou L, et al: MicroRNA-7/NF-κB signaling
regulatory feedback circuit regulates gastric carcinogenesis. J
Cell Biol. 210:613–627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Liu J, Liu C, Naji A and Stoffers
DA: MicroRNA-7 regulates the mTOR pathway and proliferation in
adult pancreatic β-cells. Diabetes. 62:887–895. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li J, Yang J, Zhou P, Le Y, Zhou C, Wang
S, Xu D, Lin HK and Gong Z: Circular RNAs in cancer: Novel insights
into origins, properties, functions and implications. Am J Cancer
Res. 5:472–480. 2015.PubMed/NCBI
|
|
41
|
Bak RO, Hollensen AK and Mikkelsen JG:
Managing microRNAs with vector-encoded decoy-type inhibitors. Mol
Ther. 21:1478–1485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Haraguchi T, Ozaki Y and Iba H: Vectors
expressing efficient RNA decoys achieve the long-term suppression
of specific microRNA activity in mammalian cells. Nucleic Acids
Res. 37:e432009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo JU, Agarwal V, Guo H and Bartel DP:
Expanded identification and characterization of mammalian circular
RNAs. Genome Biol. 15:4092014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Capel B, Swain A, Nicolis S, Hacker A,
Walter M, Koopman P, Goodfellow P and Lovell-Badge R: Circular
transcripts of the testis-determining gene Sry in adult mouse
testis. Cell. 73:1019–1030. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Martineau Y, Derry MC, Wang X, Yanagiya A,
Berlanga JJ, Shyu AB, Imataka H, Gehring K and Sonenberg N:
Poly(A)-binding protein-interacting protein 1 binds to eukaryotic
translation initiation factor 3 to stimulate translation. Mol Cell
Biol. 28:6658–6667. 2008. View Article : Google Scholar : PubMed/NCBI
|
